Durata Therapeutics to Present at the Cowen & Company 33rd Annual Health Care Conference

Durata Therapeutics to Present at the Cowen & Company 33rd Annual Health Care

CHICAGO, Feb. 20, 2013 (GLOBE NEWSWIRE) -- Durata Therapeutics (Nasdaq:DRTX)
today announced that Durata's Chief Executive Officer Paul R. Edick will
present an overview of the company at the Cowen & Company Healthcare
Conference in Boston, MA. The Durata presentation will take place at The
Boston Marriott Copley Place on Wednesday, March 6, 2013 at 9:20 a.m. EST.

About Durata Therapeutics

Durata Therapeutics is a pharmaceutical company focused on the development and
commercialization of novel therapeutics for patients with infectious diseases
and acute illnesses. Durata has completed its DISCOVER 1 study and enrollment
in its DISCOVER 2 global Phase 3 clinical trials with its lead product
candidate, dalbavancin, for the treatment of patients with acute bacterial
skin and skin structure infections, or ABSSSI.

The Durata Therapeutics, Inc. logo is available at

Forward-looking statements

Any statements in this press release about Durata's future expectations, plans
and prospects constitute forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995, as amended. Actual results
may differ materially from those indicated by such forward-looking statements.
Durata anticipates that subsequent events and developments will cause its
views to change. However, while Durata may elect to update these
forward-looking statements at some point in the future, Durata specifically
disclaims any obligation to do so.

CONTACT: Investor Relations and Public Affairs Contact
         Allison Wey - Durata Therapeutics
         Vice President, Investor Relations and Public Affairs
         (312)219-7017 - awey@duratatherapeutics.com

Durata Therapeutics, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.